Safety Alert for CAVA OPTEASE VEHICLE FILTER SYSTEM, Optease Recoverable Cava Vein Filter Model, Registration no. 80145900717, lots: See Annex 1 - Distribution List.

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by Johnson & Johnson do Brasil Ind. e Com. de Prod. para Saúde Ltda.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    1304
  • Date
    2013-10-10
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    The company informs that there is no impact to the patient if the physician identifies the problem and removes the filter. If there is incorrect implantation of the product with the hook oriented in the cranial direction, it can result in severe injury or risk to the patient's life, including but not limited to dissection, vessel drilling, filter migration with secondary damage to cardiac structures and ineffective prevention of pulmonary embolism. The manufacturer Cordis carried out the root cause investigation and implemented corrective actions.
  • Reason
    The company holding the record informs that manufacturer cordis has identified a printing error on an optease® retrievable vena cava filter product unit in which the femoral approach orientation arrow was printed in the wrong direction . the error resulted in the implantation of the head filter, which requires an additional percutaneous procedure to remove the filter.
  • Action
    The company is collecting the product in Brazil and guides: 1) Read the letter of Urgent Notice of Field Security. 2) Immediately identify and separate all products listed in the Distribution List (Annex I) to ensure that the affected product is not used. 3) Analyze, complete, sign and return the Confirmation Form (Annex II), according to the instructions on the form. 4) Return the affected product in accordance with the enclosed instructions, or contact your local sales representative to arrange for the return of the affected product. A credit will be provided. 5) Share this letter with everyone at your facility who needs to be informed of this recall. 6) Contact other facilities to arrange the return of OPTEASE®, if any of the indicated products has been sent there. 7) Keep this notice in mind until all the above products have been returned to the company that holds the registration. 8) Keep a copy of this notice along with the affected product. See letter to the Client (Annex III).

Manufacturer